Market closed on 06 Mar 2026 with TGOD.TO stock finishing at C$0.17 after 19,704,275 shares traded, making it one of the day’s most active TSX listings. The heavy volume outpaced the average daily trade of 1,585,835 shares and pushed intraday range to C$0.17–C$0.22. Investors should note the gap between the current price and the 50‑day average (C$0.24) and 200‑day average (C$0.31) as indicators of short‑term momentum and mean reversion risk in the Canadian healthcare/drug manufacturers sector.

TGOD.TO stock: intraday price and volume snapshot

TGOD.TO stock closed at C$0.17 on 06 Mar 2026 with a day low of C$0.17 and a day high of C$0.22. Volume hit 19.70M compared with an average volume of 1.59M, a relative volume of 12.43 that signals outsized attention. One clear claim: the spike in liquidity suggests short‑term traders and block flows, not necessarily fundamental news, drove activity.

TGOD.TO stock: fundamentals and key ratios

The Green Organic Dutchman Holdings Ltd. (TGOD.TO) shows trailing EPS of -0.23 and a negative PE of -0.74, reflecting recent net losses. Book value per share stands at C$0.38 and price‑to‑book is 0.45, indicating the stock trades below book. Enterprise value to sales is 1.63 and current ratio is 0.67, which points to liquidity pressure relative to peers in Healthcare.

TGOD.TO stock: liquidity, technicals and trading context

Trading action today left the price well below the 50‑day average (C$0.24) and 200‑day average (C$0.31). Technical indicators are muted on our feed but ATR is C$0.05, showing elevated absolute moves given the low price. With a year high of C$0.65 and year low of C$0.17, volatility remains high and liquidity can amplify intraday swings.

TGOD.TO stock: sector comparison and market backdrop

TGOD.TO stock sits in the Healthcare sector (Drug Manufacturers – Specialty & Generic). The Canadian healthcare sector has underperformed year‑to‑date (sector YTD -3.44%) and shows tighter margins versus broader markets. That environment pressures valuations for niche cannabis producers and increases sensitivity to regulatory and retail outcomes.

TGOD.TO stock: risks, catalysts and near‑term outlook

Key risk factors include negative profitability (ROE -89.53%) and a current ratio under 1.00, which raises short‑term funding concerns. Catalysts that could re‑rate TGOD.TO stock include stronger retail demand for organic cannabis, margin improvement, or a strategic financing announcement. Given the company’s EV of C$35.11M (enterprise value) versus current trading, any news that narrows operating losses could trigger sharp moves.

TGOD.TO stock: Meyka AI grade and analyst framework

Meyka AI rates TGOD.TO with a score of 62.96 out of 100 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The score reflects mixed signals: attractive price‑to‑book at 0.45 but persistent negative profitability and cash flow. DISCLAIMER: These grades are informational; we are not financial advisors.

Final Thoughts

TGOD.TO stock closed the session at C$0.17 on 06 Mar 2026 after 19.70M shares traded, a liquidity event that raises the probability of near‑term volatility. Fundamentals remain challenged: trailing EPS is -0.23, PE is -0.74, current ratio is 0.67, and book value per share is C$0.38. For positioning, analysts might set a conservative near‑term price target of C$0.10 and an upside scenario of C$0.35 if margins recover and retail demand improves. Meyka AI’s forecast model projects a monthly fair value of C$0.17, effectively in line with the close and implying 0.00% near‑term upside vs. the current price of C$0.17. Forecasts are model‑based projections and not guarantees. Traders focused on most active names should treat TGOD.TO as a liquidity‑driven ticker where short‑term risk management and position sizing are essential. For live data and deeper metrics visit the company site and our platform: The Green Organic Dutchman and Meyka stock page for TGOD.TO.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.